The combination of digital breast tomosynthesis (DBT) and molecular breast imaging (MBI) offered more than double the detection of invasive breast cancer with DBT in the first year of screening, according to a prospective study of nearly 3,000 women with dense breasts.

Read the full article on diagnosticimaging.com